Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minima.

How can we understand a case in which a given amino acid sequence folds into structurally and functionally distinct molecules? Synonymous single-nucleotide polymorphisms in the MDR1 (multidrug resistance 1 or ABCB1) gene involving frequent-to-rare codon substitutions lead to identical protein sequences. Remarkably, these alternative sequences give a protein product with similar but different structures and functions. Here, we propose that long-enough ribosomal pause time scales may lead to alternate folding pathways and distinct minima on the folding free energy surface. While the conformational and functional differences between the native and alternate states may be minor, the MDR1 case illustrates that the barriers may nevertheless constitute sufficiently high hurdles in physiological time scales, leading to kinetically trapped states with altered structures and functions. Different folding pathways leading to conformationally similar trapped states may be due to swapping of (fairly symmetric) segments. Domain swapping is more likely in the no-pause case in which the chain elongates and folds simultaneously; on the other hand, sufficiently long pause times between such segments may be expected to lessen the chances of swapping events. Here, we review the literature in this light.

[1]  R. Kopito,et al.  Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. , 1994, The Journal of biological chemistry.

[2]  C. Kurland,et al.  Codon usage determines translation rate in Escherichia coli. , 1989, Journal of molecular biology.

[3]  Ricardo Ehrlich,et al.  Silent mutations affect in vivo protein folding in Escherichia coli. , 2002, Biochemical and biophysical research communications.

[4]  R. Nussinov,et al.  The building block folding model and the kinetics of protein folding. , 2001, Protein engineering.

[5]  I. Ivanov,et al.  Unusual effect of clusters of rare arginine (AGG) codons on the expression of human interferon alpha 1 gene in Escherichia coli. , 1997, The international journal of biochemistry & cell biology.

[6]  J. Clarke,et al.  Apparent cooperativity in the folding of multidomain proteins depends on the relative rates of folding of the constituent domains , 2006, Proceedings of the National Academy of Sciences.

[7]  Kai Du,et al.  The ΔF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR , 2005, Nature Structural &Molecular Biology.

[8]  R. Nussinov,et al.  Molecular dynamics simulations of alanine rich β‐sheet oligomers: Insight into amyloid formation , 2002, Protein science : a publication of the Protein Society.

[9]  A. Parente,et al.  The dual-mode quaternary structure of seminal RNase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Ramachandra,et al.  Functional Characterization of Glycosylation-Deficient Human P-Glycoprotein Using A Vaccinia Virus Expression System , 2000, The Journal of Membrane Biology.

[11]  I. Braakman,et al.  Folding of CFTR is predominantly cotranslational. , 2005, Molecular cell.

[12]  G. D'alessio Oligomer evolution in action? , 1995, Nature Structural Biology.

[13]  D. Agard,et al.  Protease pro region required for folding is a potent inhibitor of the mature enzyme , 1992, Proteins.

[14]  L. Hurst,et al.  Hearing silence: non-neutral evolution at synonymous sites in mammals , 2006, Nature Reviews Genetics.

[15]  A. Spirin,et al.  Cotranslational Folding of Globin* , 1997, The Journal of Biological Chemistry.

[16]  J. Weinstein,et al.  The folding of ovalbumin. Renaturation in vitro versus biosynthesis in vitro. , 1983, The Biochemical journal.

[17]  M. Schumacher,et al.  Structural mechanism of the simultaneous binding of two drugs to a multidrug‐binding protein , 2004, The EMBO journal.

[18]  J. Brodsky,et al.  The activities and function of molecular chaperones in the endoplasmic reticulum. , 2007, Seminars in cell & developmental biology.

[19]  Z. Poljaković,et al.  Lack of Association between the C3435T Polymorphism in the Human Multidrug Resistance (MDR1) Gene and Response to Antiepileptic Drug Treatment , 2006, Epilepsia.

[20]  W. Młynarski,et al.  Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia , 2004, European journal of haematology.

[21]  K. Dill,et al.  From Levinthal to pathways to funnels , 1997, Nature Structural Biology.

[22]  Jeffrey L Brodsky,et al.  The Recognition and Retrotranslocation of Misfolded Proteins from the Endoplasmic Reticulum , 2008, Traffic.

[23]  J. Onuchic,et al.  Navigating the folding routes , 1995, Science.

[24]  S. Parvez,et al.  Conformational toxicity and sporadic conformational diseases. , 2000, Toxicology.

[25]  S Grinstein,et al.  Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. , 1994, The EMBO journal.

[26]  M. Gottesman,et al.  Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.

[27]  R Nussinov,et al.  Binding and folding: in search of intramolecular chaperone-like building block fragments. , 2000, Protein engineering.

[28]  M. Schumacher,et al.  Structural Mechanisms of QacR Induction and Multidrug Recognition , 2001, Science.

[29]  M. Sørensen,et al.  Absolute in vivo translation rates of individual codons in Escherichia coli. The two glutamic acid codons GAA and GAG are translated with a threefold difference in rate. , 1991, Journal of molecular biology.

[30]  A. Komar,et al.  Synonymous codon substitutions affect ribosome traffic and protein folding during in vitro translation , 1999, FEBS letters.

[31]  R. Kreienberg,et al.  Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer. , 2003, International journal of oncology.

[32]  C. Anfinsen Principles that govern the folding of protein chains. , 1973, Science.

[33]  Hiroshi Akashi,et al.  Translational selection and yeast proteome evolution. , 2003, Genetics.

[34]  A. Brown,et al.  The efficiency of folding of some proteins is increased by controlled rates of translation in vivo. A hypothesis. , 1987, Journal of molecular biology.

[35]  J. Wakefield,et al.  Efficient Intracellular Processing of the Endogenous Cystic Fibrosis Transmembrane Conductance Regulator in Epithelial Cell Lines* , 2004, Journal of Biological Chemistry.

[36]  I. Pastan,et al.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter. , 1999, Annual review of pharmacology and toxicology.

[37]  R. Nussinov,et al.  Folding funnels and binding mechanisms. , 1999, Protein engineering.

[38]  P. Lansbury,et al.  Amyloid fibrillogenesis: themes and variations. , 2000, Current opinion in structural biology.

[39]  E. Shakhnovich,et al.  The role of cotranslation in protein folding: a lattice model study , 2004 .

[40]  K. M. Routzahn,et al.  Maltodextrin‐binding proteins from diverse bacteria and archaea are potent solubility enhancers , 2003, FEBS letters.

[41]  D. Eisenberg,et al.  Domain swapping: entangling alliances between proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Brown,et al.  Protein folding within the cell is influenced by controlled rates of polypeptide elongation. , 1992, Journal of molecular biology.

[43]  W. Weimar,et al.  Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR‐1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus , 2003, Clinical pharmacology and therapeutics.

[44]  Lippincott-Schwartz,et al.  Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page , 2022 .

[45]  S. Markova,et al.  Genotype-dependent down-regulation of gene expression and function of MDR1 in human peripheral blood mononuclear cells under acute inflammation. , 2006, Drug metabolism and pharmacokinetics.

[46]  D. Danley,et al.  Expression of human plasminogen activator inhibitor type-1 (PAI-1) in Escherichia coli as a soluble protein comprised of active and latent forms. Isolation and crystallization of latent PAI-1. , 1990, Biochimica et biophysica acta.

[47]  R. Dawson,et al.  Structure of a bacterial multidrug ABC transporter , 2006, Nature.

[48]  M. Schumacher,et al.  Structural basis for cooperative DNA binding by two dimers of the multidrug‐binding protein QacR , 2002, The EMBO journal.

[49]  F. Hartl,et al.  Recombination of protein domains facilitated by co-translational folding in eukaryotes , 1997, Nature.

[50]  P Argos,et al.  Protein secondary structural types are differentially coded on messenger RNA , 1996, Protein science : a publication of the Protein Society.

[51]  M. Inouye,et al.  Protein memory through altered folding mediated by intramolecular chaperones , 1997, Nature.

[52]  M. Brodie,et al.  Lack of Association between the C3435T Polymorphism in the Human Multidrug Resistance (MDR1) Gene and Response to Antiepileptic Drug Treatment , 2005, Epilepsia.

[53]  M. Inouye,et al.  The structural and functional organization of intramolecular chaperones: the N-terminal propeptides which mediate protein folding. , 1994, Journal of biochemistry.

[54]  C. Kurland,et al.  Co-variation of tRNA abundance and codon usage in Escherichia coli at different growth rates. , 1996, Journal of molecular biology.

[55]  D. Baker,et al.  Contact order, transition state placement and the refolding rates of single domain proteins. , 1998, Journal of molecular biology.

[56]  L. Duret,et al.  Expression pattern and, surprisingly, gene length shape codon usage in Caenorhabditis, Drosophila, and Arabidopsis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[57]  R. Nussinov,et al.  Folding funnels, binding funnels, and protein function , 1999, Protein science : a publication of the Protein Society.

[58]  T. Rapoport,et al.  Retro-translocation of proteins from the endoplasmic reticulum into the cytosol , 2002, Nature Reviews Molecular Cell Biology.

[59]  B. Machaliński,et al.  Involvement of C3435T and G2677T multidrug resistance gene polymorphisms in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. , 2005, European journal of pharmacology.

[60]  D. Roden,et al.  The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. , 1998, The Journal of clinical investigation.

[61]  R. B. Dyer,et al.  Ultrafast and downhill protein folding. , 2007, Current opinion in structural biology.

[62]  Patricia L Clark,et al.  Protein folding in the cell: reshaping the folding funnel. , 2004, Trends in biochemical sciences.

[63]  M. Schumacher,et al.  Crystal Structures of QacR-Diamidine Complexes Reveal Additional Multidrug-binding Modes and a Novel Mechanism of Drug Charge Neutralization* , 2004, Journal of Biological Chemistry.

[64]  V. Lyakhovich,et al.  Possible Prediction of the Efficiency of Chemotherapy in Patients with Lymphoproliferative Diseases Based on MDR1 Gene G2677T and C3435T Polymorphisms , 2003, Bulletin of Experimental Biology and Medicine.

[65]  P. Sonneveld,et al.  MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia. , 2001, Blood.

[66]  Y. Teo,et al.  Effect of MDR1 haplotype on risk of Parkinson disease. , 2005, Archives of neurology.

[67]  M. Schumacher,et al.  Deciphering the molecular basis of multidrug recognition: crystal structures of the Staphylococcus aureus multidrug binding transcription regulator QacR. , 2003, Research in microbiology.

[68]  P. Clark,et al.  Conformations of co-translational folding intermediates. , 2005, Protein and peptide letters.

[69]  R. Nussinov,et al.  Anatomy of protein structures: visualizing how a one-dimensional protein chain folds into a three-dimensional shape. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[70]  G. von Heijne,et al.  Do protein-lipid interactions determine the recognition of transmembrane helices at the ER translocon? , 2005, Biochemical Society transactions.

[71]  Gerry McDermott,et al.  Structural Basis of Multiple Drug-Binding Capacity of the AcrB Multidrug Efflux Pump , 2003, Science.

[72]  Christopher M Dobson,et al.  The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation , 2002, The EMBO journal.

[73]  R. Nussinov,et al.  Folding and binding cascades: Dynamic landscapes and population shifts , 2008, Protein science : a publication of the Protein Society.

[74]  R. Nussinov,et al.  Folding and binding cascades: shifts in energy landscapes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[75]  R. Nussinov,et al.  Distinguishing between sequential and nonsequentially folded proteins: Implications for folding and misfolding , 1999, Protein science : a publication of the Protein Society.

[76]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.

[77]  M Yarus,et al.  Rates of aminoacyl-tRNA selection at 29 sense codons in vivo. , 1989, Journal of molecular biology.

[78]  W. Sugiura,et al.  Influence of Single-Nucleotide Polymorphisms in the Multidrug Resistance-1 Gene on the Cellular Export of Nelfinavir and Its Clinical Implication for Highly Active Antiretroviral Therapy , 2004, Antiviral therapy.

[79]  Charlotte M. Deane,et al.  Modelling sequential protein folding under kinetic control , 2006, ISMB.

[80]  D. Clarke,et al.  The Minimum Functional Unit of Human P-glycoprotein Appears to be a Monomer* , 1996, The Journal of Biological Chemistry.

[81]  A. Brown,et al.  The folding of the bifunctional TRP3 protein in yeast is influenced by a translational pause which lies in a region of structural divergence with Escherichia coli indoleglycerol-phosphate synthase. , 1994, European journal of biochemistry.

[82]  A Helenius,et al.  How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum. , 1994, Molecular biology of the cell.

[83]  Ozlem Keskin,et al.  Similar binding sites and different partners: implications to shared proteins in cellular pathways. , 2007, Structure.

[84]  D Eisenberg,et al.  3D domain swapping: A mechanism for oligomer assembly , 1995, Protein science : a publication of the Protein Society.

[85]  P Argos,et al.  Ribosome‐mediated translational pause and protein domain organization , 1996, Protein science : a publication of the Protein Society.